Family · Pharmaceutical analytical standards
Vardenafil
A phosphodiesterase type 5 (PDE5) inhibitor for erectile dysfunction, approved in Europe in March 2003 and in the United States the same year; it is also available as orodispersible tablets. This family brings together the active ingredient, pharmacopoeial impurities, labelled standards and other impurities.
Did you know?Its structure is almost a twin of sildenafil's: the two molecules differ in the position of a single nitrogen atom and in an ethyl group in place of a methyl.
No product matches your search.
EDQM standards 1
The official European Pharmacopoeia standards for this family.
Need a molecule you cannot find?
Custom synthesis of impurities, metabolites and labelled compounds, with the same characterisation level.
